Kathleen Skarvan - Electromed CEO and President and Director
| ELMD Stock | USD 24.73 0.26 1.04% |
CEO
Ms. Kathleen S. Skarvan serves as a President, Chief Executive Officer of the Company. She has served as the Chief Executive Officer of the Company since December 2012 and was elected to the Board in November 2013. Most recently, she was appointed to the additional position of President of the Company in August 2015. Previously, Ms. Skarvan served as Vice President of Operations at OEM Fabricators from November 2011 until October 2012. Prior to her position with OEM Fabricators, Ms. Skarvan served in various roles at Hutchinson Technology Incorporated, most recently as the President of the Disk Drive Components Division from April 2007 until March 2011. As President of the Disk Drive Components Division, Ms. Skarvan managed a public company division with annual revenues in excess of 300 million. Ms. Skarvan also served as a Senior Vice President of Hutchinson Technology Incorporated from December 2010 to March 2011, and as Vice President of Sales Marketing of the Disk Drive Components Division from October 2003 until April 2007. She has served on the Board of Trustees of the St. Cloud State University Foundation since June 2015 since 2015.
| Age | 68 |
| Tenure | 10 years |
| Address | 500 Sixth Avenue NW, New Prague, MN, United States, 56071 |
| Phone | 952 758 9299 |
| Web | https://smartvest.com |
Kathleen Skarvan Latest Insider Activity
Tracking and analyzing the buying and selling activities of Kathleen Skarvan against Electromed stock is an integral part of due diligence when investing in Electromed. Kathleen Skarvan insider activity provides valuable insight into whether Electromed is net buyers or sellers over its current business cycle. Note, Electromed insiders must abide by specific rules, including filing SEC forms every time they buy or sell Electromed'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Kathleen Skarvan over a month ago Disposition of 5000 shares by Kathleen Skarvan of Electromed at 29.15 subject to Rule 16b-3 | ||
Kathleen Skarvan over a month ago Disposition of 40000 shares by Kathleen Skarvan of Electromed at 1.8 subject to Rule 16b-3 | ||
Kathleen Skarvan over three months ago Disposition of 40185 shares by Kathleen Skarvan of Electromed subject to Rule 16b-3 | ||
Kathleen Skarvan over three months ago Disposition of 56945 shares by Kathleen Skarvan of Electromed at 27.9706 subject to Rule 16b-3 |
Electromed Management Efficiency
The company has return on total asset (ROA) of 0.109 % which means that it generated a profit of $0.109 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.1611 %, meaning that it created $0.1611 on every $100 dollars invested by stockholders. Electromed's management efficiency ratios could be used to measure how well Electromed manages its routine affairs as well as how well it operates its assets and liabilities. At present, Electromed's Return On Assets are projected to increase slightly based on the last few years of reporting. At present, Electromed's Other Current Assets are projected to increase significantly based on the last few years of reporting. The current year's Total Current Assets is expected to grow to about 53.3 M, whereas Non Currrent Assets Other are forecasted to decline to about 95 K.Similar Executives
| Found 13 records | CEO Age | ||
| Karen Zaderej | Axogen Inc | 63 | |
| Vladimir Makatsaria | LivaNova PLC | 52 | |
| Gary Maharaj | SurModics | 62 | |
| Joel Becker | Neuropace | 57 | |
| Glendon French | Pulmonx Corp | 62 | |
| Michael Dale | Axogen Inc | 65 | |
| Steven Williamson | Pulmonx Corp | 52 | |
| Albert DaCosta | Paragon 28 | 51 | |
| Joseph Dziedzic | Integer Holdings Corp | 57 | |
| Roger Susi | Iradimed Co | 72 | |
| Massimo Calafiore | Orthofix Medical | 52 | |
| Damien McDonald | LivaNova PLC | 59 | |
| Mark Throdahl | Orthopediatrics Corp | 74 | |
Management Performance
| Return On Equity | 0.16 | ||||
| Return On Asset | 0.11 |
Electromed Leadership Team
Elected by the shareholders, the Electromed's board of directors comprises two types of representatives: Electromed inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Electromed. The board's role is to monitor Electromed's management team and ensure that shareholders' interests are well served. Electromed's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Electromed's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Amy Yanta, Quality Affairs | ||
| Kathleen Skarvan, CEO and President and Director | ||
| Brad Nagel, Chief Officer | ||
| Diane Kaufman, Vice Resources | ||
| William George, Secretary | ||
| Christopher Holland, Chief Officer | ||
| James Cunniff, Director President | ||
| Bradley Nagel, Chief Officer |
Electromed Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Electromed a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.16 | ||||
| Return On Asset | 0.11 | ||||
| Profit Margin | 0.11 % | ||||
| Operating Margin | 0.16 % | ||||
| Current Valuation | 195.38 M | ||||
| Shares Outstanding | 8.56 M | ||||
| Shares Owned By Insiders | 20.54 % | ||||
| Shares Owned By Institutions | 43.55 % | ||||
| Number Of Shares Shorted | 208.43 K | ||||
| Price To Earning | 23.66 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| ZLAB | Zai Lab | |
| ASLE | AerSale Corp | |
| ATS | AT S Austria |
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Electromed. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. For information on how to trade Electromed Stock refer to our How to Trade Electromed Stock guide.You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Electromed. If investors know Electromed will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Electromed listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.158 | Earnings Share 0.75 | Revenue Per Share | Quarterly Revenue Growth 0.187 | Return On Assets |
The market value of Electromed is measured differently than its book value, which is the value of Electromed that is recorded on the company's balance sheet. Investors also form their own opinion of Electromed's value that differs from its market value or its book value, called intrinsic value, which is Electromed's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Electromed's market value can be influenced by many factors that don't directly affect Electromed's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Electromed's value and its price as these two are different measures arrived at by different means. Investors typically determine if Electromed is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Electromed's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.